Endocrine Abstracts

INTRODUCTIONWe assessed the long-term outcomes of patients managed with intermittent androgen suppression (IAS) following their enrolment in an open, non-randomised feasibility study initiated 10 years ago.PATIENTS AND METHODSAll patients were required to have been managed with androgen suppression for a minimum of 9 months and achieved PSA remissions to levels <4ng/ml. Therapy was stopped and the patients...